Global Blood Therapeutics, Inc. (GBT)


Global Blood Therapeutics, Inc. (GBT)

$47.14 USD

0.39 (0.83%)

Updated Aug 22 4:00pm

Add GBT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

GBT Daily Price Range
GBT 52-Week Price Range

GBT Stock Chart More Charts


GBT Price/Volume Stats

Current price $47.14
Prev. close $46.75
Day low $46.62
Day high $47.66
50-day MA $54.10
200-day MA $50.53
52-week high $64.94
52-week low $30.15
Volume 739,966
Avg. volume 759,493
Dividend yield N/A
Market Cap 2.83B

Global Blood Therapeutics, Inc. (GBT) Company Bio


Global Blood Therapeutics is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. The company was founded in 2012 and is based in San Francisco, California.





GBT News Stream


Event/Time News Detail
Loading, please wait...

GBT Social Stream


Loading social stream, please wait...

View Full GBT Social Stream

GBT Returns

1-mo -14.83%
3-mo -21.34%
6-mo -7.08%
1-year -7.75%
3-year 141.99%
5-year N/A
YTD 14.84%
2018 4.32%
2017 172.32%
2016 -55.30%
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4401 seconds.